Balanced news tone
News Sentiment
BSX sentiment intelligence
Boston Scientific Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-2.1% over one week, -2.7% over four weeks, trend inactive, and below fair value.
Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
77/100 classification
One-week reaction
-2.1%
Price reacting lower
Trend fit
Trend inactive
-2.7% over four weeks
Fair value
-45.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
17
Negative
8
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
The Globe and Mail
Direct company coverage
Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 16 Jul 2026 20:51
- Source
- The Globe and Mail
simplywall.st
Direct company coverage
Boston Scientific (BSX) Stock Looks Cheap On Earnings While Returns Stay Weak
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 Jul 2026 04:10
- Source
- simplywall.st
StockStory
Direct company coverage
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 07:00
- Source
- StockStory
ad-hoc-news.de
Direct company coverage
Boston Scientific stock reflects steady medtech demand
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 14 Jul 2026 00:41
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jul 2026 14:04
- Source
- Market source
Market source
Direct company coverage
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 25 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 24 Jun 2026 07:00
- Source
- Market source
IndexBox
Direct company coverage
Boston Scientific Stock Decline 2026: Guidance Cuts and Analyst Outlook - News and Statistics
- Tone
- Negative 18/100
- Event
- Guidance
- Published
- 12 Jun 2026 07:00
- Source
- IndexBox
Market source
Direct company coverage
Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Boston Scientific (NYSE: BSX) director adds 4,450 company shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Stock Titan
PR Newswire
Direct company coverage
Boston Scientific enters into $2 billion accelerated share repurchase agreement
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 18 May 2026 07:00
- Source
- PR Newswire
Investing.com Nigeria
Direct company coverage
Boston Scientific stock hits 52-week low at $53.10 By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Investing.com Nigeria
DirectorsTalk Interviews
Direct company coverage
Boston Scientific Corporation (BSX) Stock Analysis: A Promising 57.96% Potential Upside
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- DirectorsTalk Interviews
GuruFocus
Direct company coverage
Boston Scientific Corp (BSX) Stock Down 4.7% -- Now Undervalued? GF Score: 84/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- GuruFocus
Moomoo
Direct company coverage
Fund Update: 543,460 BOSTON SCIENTIFIC (BSX) Shares Added to Mawer Investment Management Ltd. Portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Moomoo
Stock Titan
Direct company coverage
Boston Scientific maps out May conference appearance, July 29 Q2 call
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
Reuters
Direct company coverage
Boston Scientific cuts annual forecast, shares rise on reset
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 22 Apr 2026 07:00
- Source
- Reuters
medwatch.com
Direct company coverage
Boston Scientific dives after disappointing clinical trial results
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 31 Mar 2026 07:00
- Source
- medwatch.com
PR Newswire
Direct company coverage
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
- Tone
- Negative 18/100
- Event
- Regulatory and legal
- Published
- 24 Mar 2026 07:00
- Source
- PR Newswire
Investing.com Nigeria
Direct company coverage
Boston Scientific stock hits 52-week low at 68.19 USD By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Mar 2026 15:46
- Source
- Investing.com Nigeria
Market source
Direct company coverage
Boston Scientific Recall And Lawsuits Test Earnings Power And Capital Plans
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 07 Mar 2026 08:00
- Source
- Market source
Medical Device Network
Direct company coverage
Boston Scientific’s shares tumble 18% despite strong FY25 growth
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- Medical Device Network
BioXconomy
Direct company coverage
Boston Scientific buys Penumbra in $14.5bn deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Jan 2026 08:00
- Source
- BioXconomy
Tokenist
Direct company coverage
BSX Shares Dip as Boston Scientific Unveils Biggest Deal in 20 Years
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jan 2026 08:00
- Source
- Tokenist
PR Newswire
Direct company coverage
Boston Scientific announces agreement to acquire Penumbra, Inc.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2026 08:00
- Source
- PR Newswire